Page last updated: 2024-09-04

vatalanib and Arteriosclerosis

vatalanib has been researched along with Arteriosclerosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Koskinen, PK; Krebs, R; Lemström, KB; Nykänen, AI; Raisky, O; Sihvola, R; Tikkanen, JM; Wood, J	1
Aaltola, EM; Alitalo, K; Häyry, PJ; Koskinen, PK; Krebs, R; Lemström, KB; Nykänen, AI; Sihvola, RK; Tikkanen, JM; Wood, J; Ylä-Herttuala, S	1

Other Studies

2 other study(ies) available for vatalanib and Arteriosclerosis

Article	Year
Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation. Transplantation, 2005, Jan-27, Volume: 79, Issue:2 Topics: Angiogenesis Inhibitors; Animals; Arteriosclerosis; Benzamides; Graft Rejection; Heart Transplantation; Imatinib Mesylate; Inflammation; Male; Muscle, Smooth, Vascular; Phthalazines; Piperazines; Platelet-Derived Growth Factor; Postoperative Complications; Pyridines; Pyrimidines; Rats; Rats, Inbred Strains; Rats, Inbred WF; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Transplantation, Homologous; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2	2005
Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis. Circulation, 2002, May-28, Volume: 105, Issue:21 Topics: Acute Disease; Angiogenesis Inhibitors; Animals; Arteriosclerosis; Chronic Disease; Disease Models, Animal; Disease Progression; Endothelial Growth Factors; Gene Transfer, Horizontal; Graft Rejection; Graft Survival; Heart Transplantation; Immunohistochemistry; In Situ Hybridization; Leukocytes, Mononuclear; Lymphokines; Macrophages; Myocardium; Phthalazines; Pyridines; Rabbits; Rats; Rats, Inbred Strains; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Transfection; Transplantation, Heterotopic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002

Article

Year

Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.

Transplantation, 2005, Jan-27, Volume: 79, Issue:2

Topics: Angiogenesis Inhibitors; Animals; Arteriosclerosis; Benzamides; Graft Rejection; Heart Transplantation; Imatinib Mesylate; Inflammation; Male; Muscle, Smooth, Vascular; Phthalazines; Piperazines; Platelet-Derived Growth Factor; Postoperative Complications; Pyridines; Pyrimidines; Rats; Rats, Inbred Strains; Rats, Inbred WF; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Transplantation, Homologous; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2

2005

Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis.

Circulation, 2002, May-28, Volume: 105, Issue:21

Topics: Acute Disease; Angiogenesis Inhibitors; Animals; Arteriosclerosis; Chronic Disease; Disease Models, Animal; Disease Progression; Endothelial Growth Factors; Gene Transfer, Horizontal; Graft Rejection; Graft Survival; Heart Transplantation; Immunohistochemistry; In Situ Hybridization; Leukocytes, Mononuclear; Lymphokines; Macrophages; Myocardium; Phthalazines; Pyridines; Rabbits; Rats; Rats, Inbred Strains; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Transfection; Transplantation, Heterotopic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002